IN2013MU03843A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03843A
IN2013MU03843A IN3843MU2013A IN2013MU03843A IN 2013MU03843 A IN2013MU03843 A IN 2013MU03843A IN 3843MU2013 A IN3843MU2013 A IN 3843MU2013A IN 2013MU03843 A IN2013MU03843 A IN 2013MU03843A
Authority
IN
India
Prior art keywords
benzyl
methylpiperidin
methylamine
methanol
pyridine
Prior art date
Application number
Other languages
English (en)
Inventor
G Sathe Dr Dhananjay
Das Dr Arijit
Subhash Patil Yogesh
L Bonde Dr Nilesh
Sampat Kekan Ankush
Original Assignee
Unichem Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US14/891,028 priority Critical patent/US9951012B2/en
Priority to JP2016557204A priority patent/JP6368794B2/ja
Application filed by Unichem Lab Ltd filed Critical Unichem Lab Ltd
Priority to BR112015025543-4A priority patent/BR112015025543B1/pt
Priority to HUE19150972A priority patent/HUE053975T2/hu
Priority to PT14869304T priority patent/PT2994454T/pt
Priority to IN3843MU2013 priority patent/IN2013MU03843A/en
Priority to EP19150972.8A priority patent/EP3539965B1/en
Priority to ES14869304T priority patent/ES2720066T3/es
Priority to SI201431159T priority patent/SI2994454T1/sl
Priority to SI201431805T priority patent/SI3539965T1/sl
Priority to PT191509728T priority patent/PT3539965T/pt
Priority to PL14869304T priority patent/PL2994454T3/pl
Priority to ES19150972T priority patent/ES2865058T3/es
Priority to PCT/IB2014/066510 priority patent/WO2015087201A1/en
Priority to MX2015015432A priority patent/MX362290B/es
Priority to EP14869304.7A priority patent/EP2994454B1/en
Priority to PL19150972T priority patent/PL3539965T3/pl
Priority to HUE14869304A priority patent/HUE042911T2/hu
Priority to TR2019/04767T priority patent/TR201904767T4/tr
Publication of IN2013MU03843A publication Critical patent/IN2013MU03843A/en
Priority to ZA2015/06551A priority patent/ZA201506551B/en
Priority to US15/590,408 priority patent/US20170240510A1/en
Priority to US15/786,195 priority patent/US20180037551A1/en
Priority to US15/868,331 priority patent/US10829450B2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/02Preparation by ring-closure or hydrogenation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/98Nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IN3843MU2013 2013-12-09 2014-12-02 IN2013MU03843A (pl)

Priority Applications (23)

Application Number Priority Date Filing Date Title
ES19150972T ES2865058T3 (es) 2013-12-09 2014-12-02 Un proceso mejorado para la preparación de (3R,4R)-(1-bencil-4-metilpiperidin-3-il)-metilamina
PL14869304T PL2994454T3 (pl) 2013-12-09 2014-12-02 Ulepszony sposób wytwarzania (3R,4R)-(1-benzylo-4-metylopiperydyn-3-ylo)metyloaminy
BR112015025543-4A BR112015025543B1 (pt) 2013-12-09 2014-12-02 processo para a preparação de (3r,4r)-(1-benzil-4- metilpiperidina-3-il)-metilamina e compostos intermediários
JP2016557204A JP6368794B2 (ja) 2013-12-09 2014-12-02 (3r,4r)−(1−ベンジル−4−メチルピペリジン−3−イル)−メチルアミンの改良された調製方法
PT14869304T PT2994454T (pt) 2013-12-09 2014-12-02 Um processo melhorado para a preparacao de (3r,4r)-(1-benzil-4- metilpiperidin-3-il)-metilamina
IN3843MU2013 IN2013MU03843A (pl) 2013-12-09 2014-12-02
PCT/IB2014/066510 WO2015087201A1 (en) 2013-12-09 2014-12-02 An improved process for the preparation of (3r,4r)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine
ES14869304T ES2720066T3 (es) 2013-12-09 2014-12-02 Mejora del proceso de preparación de (3R,4R)-(1-bencil-4-metilpiperidín-3-il)-metilamina
SI201431159T SI2994454T1 (sl) 2013-12-09 2014-12-02 Izboljšan postopek za pripravo (3R,4R)-(1-benzil-4-metil piperidin-3-il)-metil amina
SI201431805T SI3539965T1 (sl) 2013-12-09 2014-12-02 Izboljšan postopek za pripravo (3R,4R)-(1-benzil-4-metilpiperidin-3-il)-metilamina
PT191509728T PT3539965T (pt) 2013-12-09 2014-12-02 Processo melhorado para a preparação de (3r,4r)-(1-benzil-4-metilpiperidin-3-il)-metilamina
US14/891,028 US9951012B2 (en) 2013-12-09 2014-12-02 Process for the preparation of (3R,4R)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine
HUE19150972A HUE053975T2 (hu) 2013-12-09 2014-12-02 Továbbfejlesztett eljárás (3R,4R)-(1-benzil-4-metilpiperidin-3-il)-metilamin elõállítására
EP19150972.8A EP3539965B1 (en) 2013-12-09 2014-12-02 An improved process for the preparation of (3r,4r)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine
MX2015015432A MX362290B (es) 2013-12-09 2014-12-02 Un proceso mejorado para la preparacion de (3r,4r)-(1-bencilo-4-me tilpiperidina-3-il)-metilamina.
EP14869304.7A EP2994454B1 (en) 2013-12-09 2014-12-02 An improved process for the preparation of (3r,4r)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine
PL19150972T PL3539965T3 (pl) 2013-12-09 2014-12-02 Ulepszony sposób wytwarzania (3r,4r)-(1-benzylo-4-mety-lopiperydyn-3-ylo)metyloaminy
HUE14869304A HUE042911T2 (hu) 2013-12-09 2014-12-02 Javított eljárás a (3R,4R)-(1-benzil-4-metil-piperidin-3-il)-metilamin elõállítására
TR2019/04767T TR201904767T4 (tr) 2013-12-09 2014-12-02 (3R,4R)-(1-benzil-4-metilpiperidin-3-il)-metilamin hazırlanması için geliştirilmiş bir işlem.
ZA2015/06551A ZA201506551B (en) 2013-12-09 2015-09-04 An improved process for the preparation of (3r,4r)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine
US15/590,408 US20170240510A1 (en) 2013-12-09 2017-05-09 Process for the preparation of (3r,4r)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine
US15/786,195 US20180037551A1 (en) 2013-12-09 2017-10-17 Process for the Preparation of (3R,4R)-(1-BENZYL-4-METHYLPIPERIDIN-3-YL)-METHYLAMINE
US15/868,331 US10829450B2 (en) 2013-12-09 2018-01-11 Process for the preparation of (3R,4R)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3843MU2013 IN2013MU03843A (pl) 2013-12-09 2014-12-02

Publications (1)

Publication Number Publication Date
IN2013MU03843A true IN2013MU03843A (pl) 2015-08-14

Family

ID=53370688

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3843MU2013 IN2013MU03843A (pl) 2013-12-09 2014-12-02

Country Status (14)

Country Link
US (4) US9951012B2 (pl)
EP (2) EP2994454B1 (pl)
JP (1) JP6368794B2 (pl)
BR (1) BR112015025543B1 (pl)
ES (2) ES2865058T3 (pl)
HU (2) HUE053975T2 (pl)
IN (1) IN2013MU03843A (pl)
MX (1) MX362290B (pl)
PL (2) PL2994454T3 (pl)
PT (2) PT3539965T (pl)
SI (2) SI2994454T1 (pl)
TR (1) TR201904767T4 (pl)
WO (1) WO2015087201A1 (pl)
ZA (1) ZA201506551B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2994454T3 (pl) * 2013-12-09 2019-09-30 Unichem Laboratories Limited Ulepszony sposób wytwarzania (3R,4R)-(1-benzylo-4-metylopiperydyn-3-ylo)metyloaminy
JP6742323B2 (ja) 2015-01-20 2020-08-19 无▲錫▼福祈制▲薬▼有限公司Wuxi Fortune Pharmaceutical Co.,Ltd Jak阻害剤
TR201909694T4 (tr) 2015-04-29 2019-07-22 Wuxi Fortune Pharmaceutical Co Ltd Janus kinaz (jak) inhibitörleri.
MX2017013797A (es) 2015-05-29 2018-03-21 Wuxi Fortune Pharmaceutical Co Ltd Inhibidor de janus quinasa.
CN105237463B (zh) * 2015-10-09 2017-10-10 刘卫国 一种(3r,4r)‑(1‑苄基‑4‑甲基哌啶‑3‑基)甲胺‑l‑二对甲苯甲酰酒石酸盐的制备方法
CN105884781B (zh) * 2016-04-18 2018-04-20 山东罗欣药业集团股份有限公司 一种枸橼酸托法替布的制备方法
EP3301087A1 (en) * 2016-09-30 2018-04-04 DPx Fine Chemicals Austria GmbH & Co KG Process for preparing chiral amines
CN107056681B (zh) * 2017-03-30 2019-10-01 广州白云山光华制药股份有限公司 一种托法替布中间体的制备方法
CN110668995A (zh) * 2018-07-03 2020-01-10 江苏海悦康医药科技有限公司 一种枸橼酸托法替布中间体及枸橼酸托法替布的制备方法
CN114685515A (zh) * 2022-03-15 2022-07-01 上海蓝乐鸟实业有限公司 一种托法替尼的制备方法
CN115872923B (zh) * 2022-12-29 2023-04-28 成都泰和伟业生物科技有限公司 一种化合物及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06145144A (ja) 1992-11-04 1994-05-24 Ihara Chem Ind Co Ltd 新規な3−アミノピリジン誘導体第4級アンモニウム塩及びこれを有効成分とする抗癌剤
JP4671079B2 (ja) * 1999-07-05 2011-04-13 日本農薬株式会社 フタラミド誘導体、その中間体及び農園芸用殺虫剤並びにその使用方法
CN1332961C (zh) * 1999-10-20 2007-08-22 田边制药株式会社 αLβ2介导细胞粘连抑制剂
PL218519B1 (pl) 1999-12-10 2014-12-31 Pfizer Prod Inc Związki pirolo [2,3-d] pirymidynowe, środek farmaceutyczny zawierający te związki oraz ich zastosowanie
EA007485B1 (ru) 2001-02-24 2006-10-27 Берингер Ингельхайм Фарма Гмбх Унд Ко. Кг Производные ксантина, способ их получения, фармацевтическая композиция на их основе и способ ее получения
US7301023B2 (en) 2001-05-31 2007-11-27 Pfizer Inc. Chiral salt resolution
GT200200234A (es) * 2001-12-06 2003-06-27 Compuestos cristalinos novedosos
DE602005013819D1 (de) * 2004-12-22 2009-05-20 Astrazeneca Ab Pyridincarbonsäureamidderivate zur verwendung als antikrebsmittel
AU2006273762A1 (en) * 2005-07-29 2007-02-01 Pfizer Products Inc. Pyrrolo[2,3-d]pyrimidine derivatives; their intermediates and synthesis
WO2008029237A2 (en) * 2006-09-05 2008-03-13 Pfizer Products Inc. Combination therapies for rheumatoid arthritis
CA2732628A1 (en) * 2008-08-01 2010-02-04 Biocryst Pharmaceuticals, Inc. Therapeutic agents
RU2011146059A (ru) 2009-04-14 2013-05-20 Астеллас Фарма Инк. Конденсированное пирролопиридиновое производное
JP5709276B2 (ja) 2009-04-20 2015-04-30 オースペックス ファーマシューティカルズ,エルエルシー ヤヌスキナーゼ3のピペリジンインヒビター
EP2456435B1 (en) * 2009-07-21 2015-06-24 The Board of Trustees of the Leland Stanford Junior University Heteroaryl benzamides, compositions and methods of use
EA021437B1 (ru) * 2009-09-29 2015-06-30 Глэксо Груп Лимитед Соединения, ингибирующие lrrk2 киназную активность
PL2994454T3 (pl) * 2013-12-09 2019-09-30 Unichem Laboratories Limited Ulepszony sposób wytwarzania (3R,4R)-(1-benzylo-4-metylopiperydyn-3-ylo)metyloaminy

Also Published As

Publication number Publication date
JP2017503007A (ja) 2017-01-26
PL3539965T3 (pl) 2021-07-05
WO2015087201A1 (en) 2015-06-18
SI3539965T1 (sl) 2021-07-30
ZA201506551B (en) 2017-02-22
BR112015025543B1 (pt) 2020-11-03
US9951012B2 (en) 2018-04-24
HUE053975T2 (hu) 2021-08-30
JP6368794B2 (ja) 2018-08-01
US20170240510A1 (en) 2017-08-24
US20180037551A1 (en) 2018-02-08
EP2994454A1 (en) 2016-03-16
PL2994454T3 (pl) 2019-09-30
EP3539965B1 (en) 2021-01-20
PT2994454T (pt) 2019-04-02
EP2994454A4 (en) 2016-12-21
EP2994454B1 (en) 2019-03-06
ES2720066T3 (es) 2019-07-17
ES2865058T3 (es) 2021-10-14
SI2994454T1 (sl) 2019-05-31
PT3539965T (pt) 2021-04-07
HUE042911T2 (hu) 2019-07-29
MX362290B (es) 2019-01-10
US20180134661A1 (en) 2018-05-17
US20160102057A1 (en) 2016-04-14
MX2015015432A (es) 2016-03-15
US10829450B2 (en) 2020-11-10
EP3539965A1 (en) 2019-09-18
TR201904767T4 (tr) 2019-05-21
BR112015025543A2 (pt) 2017-07-18

Similar Documents

Publication Publication Date Title
IN2013MU03843A (pl)
MY156546A (en) Process for the regioselective preparation of 1-alkyl-3-haloalkylpyrazole-4-carboxylic acid derivatives
MY201120A (en) Intermediates for use in a process of producing pyrrole compounds
MX2010009003A (es) Ciclohexanodimetanamina por aminacion directa de ciclohexanodimetanol.
SA515361251B1 (ar) طريقة لزيادة تكوين حمض بيرو-جلوتاميك من بروتين
JOP20160185B1 (ar) طريقة لتحضير (4s)-4-(4- سيانو-2- ميثوكسي فنيل)-5- إيثوكسي-8،2-داي ميثيل-4،1-داي هيدرو-6،1- نافثيريدين-3- كربوكساميد واسترجاع (4s)-4-(4- سيانو-2- ميثوكسي فنيل)-5- إيثوكسي-8،2- داي ميثيل-4،1- داي هيدرو-6،1- نافثيريدين-3- كربوكساميد بواسطة طرق كهروكيميائية
WO2013121436A3 (en) A process for preparation of rivaroxaban and intermediates thereof
MX368142B (es) Metodo de clonacion, expresion y purificacion novedoso para la preparacion de ranibizumab.
IN2015KN00323A (pl)
WO2014057498A3 (en) Process for the preparation of cobicistat intermediates
MX364960B (es) Precursor de dioxoxido de cloro y metodos de uso del mismo.
EP2463266A4 (en) PROCESS FOR PRODUCING BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE
GB2533072A (en) Biomass processing method
MY155284A (en) Process for the preparation of ajoene
UA106724C2 (uk) Спосіб отримання заміщених піримідинових похідних
MX337357B (es) Excipiente para tableteado a base de lactosa y celulosa.
MX2010009931A (es) Proceso para la preparacion de 2-amino-2-[2-(4-c3-c21-alquil-fenil )-etil]-propano-1,3-dioles.
EP2743379A4 (en) METHOD OF MANUFACTURING ELECTRO-SEPARATION AND FINISHING METAL CHLORIDE BY A MEMBRANE METHOD AND METHOD FOR PRODUCING A SELECTIVE CATION MEMBRANE THEREFOR
MY163020A (en) A process for the preparation of etoricoxib
WO2011027359A3 (en) Process for the preparation of 4 -hydroxy atomoxetine and intermediates in the manufacture thereof
MX2015003237A (es) Metodos para producir molindona y sus sales.
MX345822B (es) Separacion de enantiomeros derivados de triazina usando acido tartarico.
BR112015009139A2 (pt) processo de produção de soforose a partir de soforolipídios
MX2014004847A (es) Procedimiento para la preparacion y estabilizacion de composiciones de policarbonato modificadas al impacto usando disoluciones diluidas de compuestos acidos.
EA201101613A1 (ru) Способ получения севеламера